Paris, France/Saint-Prex, Switzerland – Ferring Pharmaceuticals a research-driven, specialty biopharmaceutical group and the Institut Pasteur, a non-profit international biomedical research center in Paris (France) today announced a collaboration aimed at identifying and developing bacteriophages to treat patients suffering from inflammatory bowel disease (IBD).
Newsroom
Thursday, 16 April 2015